Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: Inflammation and Coronary Artery Disease. Role of AT1 Receptor Antagonism

NCT00274144 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00274144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: Inflammation and Coronary Artery Disease. Role of AT1 Receptor Antagonism
Lead sponsor
Boehringer Ingelheim
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2001
Completion date
May 31, 2004
Enrollment
42
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arteriosclerosis, hypertension